Profilo
Jeffrey R.
Latts is an Independent Director at Allos Therapeutics, Inc. since 2007.
Previously, he served as the Chief Medical Officer at Berlex, Inc. from 1990 to 2001.
He then worked as the Executive Vice President at Exelixis, Inc. from 2001 to 2007.
Additionally, he has held positions as the Chief Medical Advisor at Virobay, Inc. and as the Vice President-Clinical Research at Wyeth-Ayerst Research.
Dr. Latts completed his undergraduate and doctorate degrees at the University of Minnesota.
Posizioni attive di Jeffrey R. Latts
| Società | Posizione | Inizio |
|---|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Direttore/Membro del Consiglio | 25/04/2007 |
Precedenti posizioni note di Jeffrey R. Latts
| Società | Posizione | Fine |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 12/01/2007 |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/01/2001 |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Jeffrey R. Latts
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth-Ayerst Research |
















